189 related articles for article (PubMed ID: 16426000)
21. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J; Hamdi H; Roy C; Baron G; Lemann M; Puéchal X; Breban M; Berenbaum F; Humbert M; Weldingh K; Salmon D; Ravaud P; Emilie D; Mariette X;
Ann Rheum Dis; 2007 Dec; 66(12):1610-5. PubMed ID: 17456528
[TBL] [Abstract][Full Text] [Related]
23. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.
Mantegani P; Piana F; Codecasa L; Galli L; Scarpellini P; Lazzarin A; Cirillo D; Fortis C
Clin Med Res; 2006 Dec; 4(4):266-72. PubMed ID: 17210976
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
[TBL] [Abstract][Full Text] [Related]
25. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
[TBL] [Abstract][Full Text] [Related]
26. [New immunological tests in the diagnosis of tuberculosis].
Lagrange PH; Simonney N; Herrmann JL
Rev Mal Respir; 2007 Apr; 24(4 Pt 1):453-72. PubMed ID: 17468703
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
[TBL] [Abstract][Full Text] [Related]
28. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
29. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.
van Loon W; Gomez MP; Jobe D; Franken KLMC; Ottenhoff THM; Coninx M; Kestens L; Sutherland JS; Kampmann B; Tientcheu LD
BMC Infect Dis; 2020 Jul; 20(1):469. PubMed ID: 32615981
[TBL] [Abstract][Full Text] [Related]
30. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.
Vilaplana C; Ruiz-Manzano J; Gil O; Cuchillo F; Montané E; Singh M; Spallek R; Ausina V; Cardona PJ
Scand J Immunol; 2008 Jun; 67(6):610-7. PubMed ID: 18397200
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
32. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.
Weinfurter P; Blumberg HM; Goldbaum G; Royce R; Pang J; Tapia J; Bethel J; Mazurek GH; Toney S; Albalak R;
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1056-61. PubMed ID: 21740668
[TBL] [Abstract][Full Text] [Related]
33. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test.
Soborg B; Andersen AB; Larsen HK; Weldingh K; Andersen P; Kofoed K; Ravn P
Scand J Infect Dis; 2007; 39(6-7):554-9. PubMed ID: 17577817
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.
Shakak AO; Khalil EA; Musa AM; Salih KA; Bashir AE; Ahmed AH; Idris FE; Elhassan AM;
BMC Public Health; 2013 Dec; 13():1128. PubMed ID: 24313987
[TBL] [Abstract][Full Text] [Related]
35. [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].
Harada N; Higuchi K; Sekiya Y; Rothel J; Kitoh T; Mori T
Kekkaku; 2004 Dec; 79(12):725-35. PubMed ID: 15782618
[TBL] [Abstract][Full Text] [Related]
36. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
37. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.
Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Jeffries DJ; Lugos MD; Donkor SA; Adetifa IM; de Jong BC; Aiken AM; Adegbola RA; McAdam KP
PLoS Med; 2007 Jun; 4(6):e192. PubMed ID: 17564487
[TBL] [Abstract][Full Text] [Related]
39. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.
Mori T; Sakatani M; Yamagishi F; Takashima T; Kawabe Y; Nagao K; Shigeto E; Harada N; Mitarai S; Okada M; Suzuki K; Inoue Y; Tsuyuguchi K; Sasaki Y; Mazurek GH; Tsuyuguchi I
Am J Respir Crit Care Med; 2004 Jul; 170(1):59-64. PubMed ID: 15059788
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
